Institutional Ownership
Beone Medicines Ltd
CUSIP 07725L102SPONSORED ADSONCQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
15.7%
Max % of class reported
Institutional Holders
278
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest May 13, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | May 13, 2025 | Hhlr Advisors, Ltd. | 13D/A | 4.9% | — | SEC |
| 2 | Mar 3, 2025 | Hhlr Advisors, Ltd. | 13D/A | 6.7% | — | SEC |
| 3 | Dec 10, 2024 | Baker Bros. Advisors LP | 13D/A | 9.0% | 124.82M | SEC |
| 4 | Dec 4, 2024 | Hhlr Advisors, Ltd. | 13D/A | 9.0% | 125.05M | SEC |
| 5 | Feb 5, 2024 | Oyler John | 13G/A | 5.2% | 71.46M | SEC |
| 6 | Nov 14, 2023 | Baker Bros. Advisors LP | 13D/A | 10.2% | 138.22M | SEC |
| 7 | May 5, 2023 | Baker Bros. Advisors LP | 13D/A | 11.2% | 152.52M | SEC |
| 8 | Feb 14, 2023 | Hhlr Advisors, Ltd. | 13D/A | 10.9% | 147.04M | SEC |
| 9 | Feb 10, 2023 | Oyler John | 13G/A | 5.1% | 70.03M | SEC |
| 10 | Feb 10, 2023 | Invesco Ltd. | 13G/A | 2.6% | 35.68M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Beone Medicines Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 8.80M | $2.61B |
| 2 | Primecap Management Co/Ca/ | 4.98M | $1.48B |
| 3 | Capital International Investors | 4.16M | $1.23B |
| 4 | Fmr LLC | 3.69M | $1.10B |
| 5 | Capital World Investors | 1.62M | $481.89M |
| 6 | Hhlr Advisors, Ltd. | 1.03M | $307.16M |
| 7 | Citadel Advisors LLC | 1.03M | $306.56M |
| 8 | Temasek Holdings (Private) Ltd | 862.6K | $256.18M |
| 9 | Blackrock, Inc. | 657.5K | $195.26M |
| 10 | Siren, L.L.C. | 465.0K | $138.09M |